<?xml version="1.0" encoding="utf-8"?> <rss version="2.0"><channel><title>RSS Feed on Applied Radiology</title><link>http://www.appliedradiology.com</link><description> RSS Feed on Applied Radiology</description><item><title>Recurrence of colorectal cancer, mucinous type</title><link>http://www.appliedradiology.com//Issues/2001/06/Cases/Recurrence-of-colorectal-cancer,-mucinous-type.aspx</link><description>&lt;p&gt;The patient is a 64-year-old Hispanic man who underwent
resection of mucinous, moderately well-differentiated
adenocarcinoma of the rectosigmoid (Stage T3N1M0; Duke's C) in July
1996. At the time of surgery, his serum carcinoembryonic antigen
(CEA) level was 3.5 ng/mL. In December 1997, he had a second
surgery for recurrence, after which he completed a course of remote
after-loading high-dose-rate irradiation via intraoperative
interstitial implant. During a left herniorrhaphy procedure in
August 1998, a deep-needle biopsy of the presacral area was
performed, revealing mucinous, metastatic colonic adenocarcinoma.
Although serum CEA assay results were within normal limits (2.0
ng/mL); the tumor tissues were CEA-membrane positive. In the months
immediately preceding and following the biopsy, an F-18
fluorodeoxyglucose (FDG) positron emission tomography (PET) scan,
magnetic resonance imaging (MRI) study, and a nuclear imaging study
with arcitumomab were performed (figures 1 through 3).&lt;/p&gt;</description><author></author><pubDate>Tuesday, 01 Feb 2005 13:47:46 GMT</pubDate></item></channel></rss>